You are here: Industry Insights > CDMO

News List

Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors firstwordpharma
June 10, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical
MedPharm expands topical and transdermal delivery services cphi-online
June 03, 2021
A new location in Raleigh-Durham, North Carolina, close to the CDMO's Center of Excellence, will double its current footprint
MedPharm Opens New Manufacturing Facility contractpharma
June 02, 2021
State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.
August Bioservices Expands U.S. Biopharma Manufacturing Capabilities contractpharma
May 28, 2021
?August Bioservices, LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
Hovione and iBET Form Strategic Collaboration contractpharma
May 28, 2021
?Contract development and manufacturing organization (CDMO) Hovione announced it has re-joined the membership of the Instituto de Biologia Experimental e Tecnológica (iBET). In 1989, Hovione was a founding member of iBET.
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership prnasia
May 27, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered into an exclusive contract ...
Clean Biologics buys CDMO Biodextris cphi-online
May 27, 2021
Transaction enables ArchiMed-backed biopharmaceutical services group to establish North American presence and expand activities with complementary services
Tergus Pharma Opens New HQ & Commercial Manufacturing Facility contractpharma
May 26, 2021
Tergus Pharma, a topical contract development and manufacturing organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
CDMO sector are the big winner of the pandemic, state experts europeanpharmaceuticalreview
May 25, 2021
In a presentation, experts revealed that contract services gained significantly through pandemic contracts but cautioned that capacity shortages could continue.
Recro Pharma, Astex Enter Drug Development Alliance contractpharma
May 19, 2021
Recro Pharma, Inc., a CDMO providing services for complex formulation and manufacturing challenges for oral solid dose drug products, has signed a new development agreement with Astex Pharmaceuticals, Inc.